Matrix Metalloproteinase 2
"Matrix Metalloproteinase 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.
Descriptor ID |
D020778
|
MeSH Number(s) |
D08.811.277.656.300.480.205.352 D08.811.277.656.300.480.252.420 D08.811.277.656.300.480.525.700.150 D08.811.277.656.675.374.205.352 D08.811.277.656.675.374.252.420 D08.811.277.656.675.374.525.700.150 D12.644.276.848.150 D12.776.467.836.150
|
Concept/Terms |
Matrix Metalloproteinase 2- Matrix Metalloproteinase 2
- Metalloproteinase 2, Matrix
- 72-kDa Gelatinase
- 72 kDa Gelatinase
- Gelatinase, 72-kDa
- 72-kDa Type IV Collagenase
- 72 kDa Type IV Collagenase
- MMP-2 Metalloproteinase
- MMP 2 Metalloproteinase
- Metalloproteinase, MMP-2
- Gelatinase A
- MMP2 Metalloproteinase
- Metalloproteinase, MMP2
- Matrix Metalloproteinase-2
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 2".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 2".
This graph shows the total number of publications written about "Matrix Metalloproteinase 2" by people in this website by year, and whether "Matrix Metalloproteinase 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 5 | 5 |
1997 | 0 | 6 | 6 |
1998 | 0 | 4 | 4 |
1999 | 0 | 7 | 7 |
2000 | 3 | 2 | 5 |
2001 | 1 | 7 | 8 |
2002 | 4 | 9 | 13 |
2003 | 4 | 2 | 6 |
2004 | 5 | 2 | 7 |
2005 | 1 | 11 | 12 |
2006 | 7 | 6 | 13 |
2007 | 3 | 9 | 12 |
2008 | 2 | 6 | 8 |
2009 | 2 | 2 | 4 |
2010 | 2 | 6 | 8 |
2011 | 2 | 5 | 7 |
2012 | 1 | 6 | 7 |
2013 | 2 | 1 | 3 |
2014 | 0 | 4 | 4 |
2015 | 2 | 4 | 6 |
2016 | 2 | 4 | 6 |
2017 | 2 | 1 | 3 |
2018 | 1 | 1 | 2 |
2019 | 1 | 0 | 1 |
2020 | 1 | 2 | 3 |
2021 | 0 | 1 | 1 |
2022 | 0 | 2 | 2 |
2023 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 2" by people in Profiles.
-
Polygalacturonic acid partially inhibits matrix metalloproteinases and dehydration in wounds. Wounds. 2024 07; 36(7):216-220.
-
MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study. Circ Heart Fail. 2023 11; 16(11):e010849.
-
GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes. Cell Death Dis. 2022 05 20; 13(5):481.
-
APOL1 Kidney Risk Variants and Proteomics. Clin J Am Soc Nephrol. 2022 05; 17(5):684-692.
-
Tendon and motor phenotypes in the Crtap-/- mouse model of recessive osteogenesis imperfecta. Elife. 2021 05 26; 10.
-
Non-genetic cell-surface modification with a self-assembling molecular glue. Chem Commun (Camb). 2021 Feb 15; 57(12):1470-1473.
-
Anti-fibrotic effects of different sources of MSC in bleomycin-induced lung fibrosis in C57BL6 male mice. Respirology. 2021 02; 26(2):161-170.
-
miR-18a Inhibits BMP4 and HIF-1a Normalizing Brain Arteriovenous Malformations. Circ Res. 2020 10 09; 127(9):e210-e231.
-
Effects of exercise training and detraining on atheromatous matrix metalloproteinase activity in mice. Atherosclerosis. 2020 04; 299:15-23.
-
Infiltration of CD68+ cells correlates positively with matrix metalloproteinase 2 expression in the arteries used as aortocoronary bypass grafts. Possible clinical implications. Cardiol J. 2020; 27(6):817-824.